Summary
The mechanisms of rHu-EPO attenuating the apoptosis after myocardial infraction in rats were studied. Thirty-two rats wre divided into three groups: sham operation group (Sham), acute myocardial infarction group (MI) and rHu-EPO-treated group (MI+EPO). Acute myocardial infarction model was made by ligating the anterior descending coronary artery. rHu-EPO was administered i. p. in MI+EPO group at the dose of 5 000 IU/kg body weight immediately after the ligation. Each rat in MI+EPO group received the same dose of rHu-EPO daily the next 6 days. On the 14th day all rats underwent hemodynamic measurements and then killed. The samples were examined with HE stain, immunohistochemistry technique (bcl-2, bax) and TUNEL dyeing. The results showed that hemodynamic function in MI+EPO group was much better than in MI group. The number of the cells positive for bax and TUNEL in MI+EPO group was less than that in MI group. The number of the cells positive for bcl-2 in MI+EPO group was more than that in MI group. These findings suggested that rHu-EPO could treat myocardial infarction by preventing apoptosis and attenuating post-infarction deterioration in hemodynamic function.
Similar content being viewed by others
References
Linde T, Wikstrom B, Andersson L Get al. Renal anaemia treatment with recombinant human erythropoietin increases cardiac output in patients with ischaemic heart disease. Scand J Urol Nephrol, 1996, 30:115
Chong Z Z, Kang J Q, Maiese K. Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circulation, 2002, 106:2973
Tramontano A F, Muniyappa R, Black A Det al. Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway. Biochem Biophys Res Commun, 2003, 380:990
Palojoki E, Saraste A, Eriksson Aet al. Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am J Physiol Heart Circ Physiol, 2001, 280:2726
Sakanaka M, Wen T C, Matsuda Set al. In vivo evidence that erythropoietin protect neurons from ischemic damage. Proc Natl Acad USA, 1998, 95:4635
Siren A L, Fratelli M, Brines Met al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci USA, 2001, 98:4044
Celik M, Gokmen N, Erbayraktar Set al. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci USA, 2002, 99:2258
Junk A K, Mammis A, Savitz S Iet al. Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci USA, 2002, 99:10 659
Cheung J Y, Miller B A. Molecular mechanisms of erythropoietin signaling. Nephron, 2001, 87:215
Author information
Authors and Affiliations
Additional information
YE Liang, male, born in 1978, Graduate Student
This project was supported by a grant from Natural Sciences Foundation of Hubei Province (No. 2002AB105).
Rights and permissions
About this article
Cite this article
Liang, Y., Xinling, D., Jiahong, X. et al. Effects of rHu-EPO on myocyte apoptosis and cardiac function following acute myocardial infarction in rats. Current Medical Science 25, 55–58 (2005). https://doi.org/10.1007/BF02831387
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02831387